Sensitive Skin
Conditions
Brief summary
The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
Interventions
DRUGbFGF
Half-face randomized control
DRUGBovine Basic Gel
Bovine Basic Gel
Sponsors
Shanghai Dermatology Hospital
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
1. Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3 2. No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out 3. Physical sunscreen should be strict during enrollment
Exclusion criteria
1. Children 2. Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise 3. Patients with mental illness or cancer 4. Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months 5. Those who are allergic to basic fibroblast growth factor gel and its components 6. Acute dermatitis of the face and perifolliculitis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| erythema index | 0、1、2、4 week | The change rate in lesion clearance of face at 1 month after treatment will be measured as the primary outcome |
Countries
China
Contacts
Primary ContactHaiyan Zhang, MD PhD
Backup Contactxiuli Wang, MD PhD
Outcome results
None listed